Table 3.
Most common indication for ceftriaxone utilization
| Diseases | Responses | |
|---|---|---|
| N | % | |
| Pneumonia | 40 | 18.5 |
| Sepsis | 14 | 6.5 |
| CHF | 14 | 6.5 |
| TB | 14 | 6.5 |
| Anemia | 6 | 2.8 |
| UTI | 6 | 2.8 |
| PUD | 5 | 2.3 |
| Stroke | 5 | 2.3 |
| RVI | 4 | 1.9 |
| Lung cancer | 3 | 1.4 |
| Meningitis | 3 | 1.4 |
| Hepatoma | 3 | 1.4 |
| CML | 3 | 1.4 |
| parapneumonic effusion | 3 | 1.4 |
| Abscess | 2 | 0.9 |
| CLD | 2 | 0.9 |
| Lung fibrosis | 2 | 0.9 |
| CRF | 2 | 0.9 |
| Ascites | 2 | 0.9 |
Key: CHF Congestive Heart Failure, TB Tuberculosis, UTI Urinary tract infection, PUD Peptic ulcer disease, RVI Retroviral infection, CML Chronic myeloid leukaemia, CLD Chronic liver disease, CRF Chronic renal failure